×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Human Milk Oligosaccharides Market

ID: MRFR/FnB/13837-HCR
128 Pages
Snehal Singh
October 2025

US Human Milk Oligosaccharides Market Research Report: By Application (Infant Formula, Functional Foods, Dietary Supplements), By Source (Human Milk, Synthetic Production, Animal Milk), By Form (Powder, Liquid, Capsules) and By End Use (Healthcare, Food and Beverages, Nutraceuticals) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Human Milk Oligosaccharides Market Infographic
Purchase Options

US Human Milk Oligosaccharides Market Summary

As per MRFR analysis, the US human milk-oligosaccharides market size was estimated at 121.8 USD Million in 2024. The US human milk-oligosaccharides market is projected to grow from 139.19 USD Million in 2025 to 528.76 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 14.28% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The US human milk-oligosaccharides market is experiencing robust growth driven by evolving consumer preferences and innovative product offerings.

  • Rising consumer awareness regarding the health benefits of human milk-oligosaccharides is shaping market dynamics.
  • The infant nutrition segment remains the largest, while the personalized nutrition segment is emerging as the fastest-growing area.
  • Regulatory support and innovation are fostering a conducive environment for market expansion and product development.
  • Key market drivers include the growing demand for infant nutrition and the shift towards clean label products.

Market Size & Forecast

2024 Market Size 121.8 (USD Million)
2035 Market Size 528.76 (USD Million)

Major Players

Nestle (CH), Danone (FR), Bifidobacterium (DE), FrieslandCampina (NL), Synlogic (US), Ginkgo Bioworks (US), Ferring Pharmaceuticals (CH), Evolva (CH)

US Human Milk Oligosaccharides Market Trends

the human milk-oligosaccharides market is experiencing significant growth, driven by increasing awareness of the health benefits associated with oligosaccharides found in human milk. These complex carbohydrates are recognized for their role in promoting gut health, enhancing immune function, and supporting cognitive development in infants. As parents become more informed about nutrition, the demand for products containing human milk-oligosaccharides is likely to rise. This trend is further supported by ongoing research highlighting the potential advantages of these compounds in infant formula and other dietary products. Moreover, the regulatory landscape in the US appears to be evolving, with agencies focusing on the safety and efficacy of human milk-oligosaccharides in various applications. This regulatory support may encourage manufacturers to innovate and expand their product lines, thereby increasing market accessibility. Additionally, the growing trend of personalized nutrition could lead to tailored products that incorporate human milk-oligosaccharides, appealing to health-conscious consumers. As the market continues to develop, it seems poised for further expansion, reflecting a shift towards more health-oriented dietary choices among families.

Rising Consumer Awareness

There is a growing recognition among consumers regarding the health benefits of human milk-oligosaccharides. This awareness is influencing purchasing decisions, particularly among parents seeking optimal nutrition for their infants. As educational initiatives increase, the demand for products enriched with these oligosaccharides is likely to grow.

Regulatory Support and Innovation

The evolving regulatory framework in the US is fostering innovation within the human milk-oligosaccharides market. Agencies are increasingly focusing on the safety and efficacy of these compounds, which may encourage manufacturers to develop new products that meet consumer needs while adhering to safety standards.

Personalized Nutrition Trends

The trend towards personalized nutrition is gaining traction, with consumers seeking tailored dietary solutions. This shift may lead to the development of specialized products that incorporate human milk-oligosaccharides, catering to individual health requirements and preferences.

US Human Milk Oligosaccharides Market Drivers

Expansion of E-commerce Platforms

The human milk-oligosaccharides market is being positively impacted by the expansion of e-commerce platforms. The convenience of online shopping has transformed consumer purchasing behaviors, particularly among parents seeking infant nutrition products. E-commerce allows for greater accessibility to specialized products containing human milk-oligosaccharides, which may not be readily available in traditional retail outlets. Recent statistics suggest that online sales of infant formula are projected to grow by over 15% annually, indicating a shift in consumer preferences. This trend not only facilitates market penetration for manufacturers but also enhances consumer awareness and education regarding the benefits of human milk-oligosaccharides, thereby driving overall market growth.

Shift Towards Clean Label Products

The human milk-oligosaccharides market is benefiting from a significant shift towards clean label products. Consumers are increasingly seeking transparency in food labeling, preferring products that are free from artificial additives and preservatives. This trend is particularly pronounced among parents purchasing infant nutrition products, who prioritize natural ingredients. As a response, manufacturers are reformulating their products to include human milk-oligosaccharides, which are perceived as a natural and beneficial ingredient. This shift is reflected in market data, indicating that clean label products are expected to capture a larger share of the infant formula market, potentially reaching 30% by 2026. Such developments suggest that the human milk-oligosaccharides market is well-positioned to thrive in this evolving landscape.

Growing Demand for Infant Nutrition

The human milk-oligosaccharides market is experiencing a notable surge in demand driven by the increasing focus on infant nutrition. Parents are becoming more aware of the nutritional benefits associated with human milk-oligosaccharides, which are known to support immune function and gut health in infants. According to recent data, the infant formula segment, which incorporates these oligosaccharides, is projected to grow at a CAGR of approximately 8% over the next five years. This growth reflects a broader trend towards premium infant nutrition products, as parents seek to provide the best possible start for their children. Consequently, manufacturers are expanding their product lines to include human milk-oligosaccharides, thereby enhancing their market presence and catering to the evolving preferences of health-conscious consumers.

Rising Health Consciousness Among Consumers

The human milk-oligosaccharides market is experiencing growth due to rising health consciousness among consumers. As awareness of the importance of gut health and immune support increases, parents are more inclined to choose products that contain beneficial ingredients like oligosaccharides. This trend is particularly evident in the U.S., where health-focused marketing strategies are gaining traction. Data indicates that products enriched with human milk-oligosaccharides are perceived as superior, leading to higher sales in the infant nutrition sector. The increasing emphasis on preventive health measures is likely to further bolster the demand for these products, positioning the human milk-oligosaccharides market for sustained growth in the coming years.

Increased Research and Development Activities

The human milk-oligosaccharides market is significantly influenced by heightened research and development activities. Scientific studies continue to unveil the health benefits of oligosaccharides, including their role in promoting gut microbiota and reducing the risk of infections in infants. As a result, companies are investing heavily in R&D to innovate and develop new products that incorporate these beneficial compounds. The U.S. market has seen a rise in collaborations between academic institutions and industry players, leading to advancements in oligosaccharide extraction and formulation techniques. This focus on innovation not only enhances product efficacy but also drives consumer interest, thereby contributing to the overall growth of the human milk-oligosaccharides market.

Market Segment Insights

By Application: Infant Formula (Largest) vs. Functional Foods (Fastest-Growing)

In the US human milk-oligosaccharides market, the application segment showcases a diverse distribution, with Infant Formula holding the largest market share. This segment is preferred by consumers due to its critical role in infant nutrition and its growing acceptance among parents. Functional Foods follow as a notable contender, reflecting a significant uptake among health-conscious consumers seeking to enhance their diets through enhanced nutritional options. The growth trends indicate that while Infant Formula continues to dominate, Functional Foods are quickly emerging as the fastest-growing segment. This growth is driven by increasing awareness of health benefits associated with oligosaccharides, coupled with rising demand for fortified food products. Additionally, the expansion of dietary supplements is contributing to the overall positive outlook for the segment, as more consumers discover the advantages of incorporating these products into their daily routines.

Infant Formula: Dominant vs. Dietary Supplements: Emerging

Infant Formula remains the dominant segment in the US human milk-oligosaccharides market, characterized by its established presence and strong consumer trust. This segment benefits from extensive research and development, resulting in tailored formulations that cater to the nutritional needs of infants. On the other hand, Dietary Supplements represent an emerging segment, gaining traction as consumers increasingly seek additional health benefits from their diets. These supplements are often marketed for their immune-boosting properties and overall gut health, appealing particularly to parents concerned about their children's nutritional intake. Both segments reflect a growing inclination towards improved health outcomes, albeit with differing target demographics and marketing strategies.

By Source: Human Milk (Largest) vs. Synthetic Production (Fastest-Growing)

The market share distribution in the US human milk-oligosaccharides market shows that Human Milk holds a significant portion, indicating its established preference among consumers, primarily due to its natural origin and nutritional benefits. Synthetic Production, while currently smaller in share, is gaining traction and is projected to expand due to advancements in biotechnology and increased consumer acceptance of lab-made ingredients. Growth trends indicate a rising demand for Human Milk as it is viewed as the most beneficial source for infants. However, the innovations in Synthetic Production are leading to rapid growth in this segment, driven by improvements in production technology and the ability to provide a more sustainable and cost-effective solution. This shift is expected to reshape preferences and market dynamics in the coming years.

Human Milk: Dominant vs. Synthetic Production: Emerging

Human Milk remains the dominant source in the US human milk-oligosaccharides market, celebrated for its extensive health benefits and suitability for infant nutrition. It is derived directly from breastfeeding mothers, making it highly preferred by health-conscious parents. On the other hand, Synthetic Production represents an emerging segment that leverages biotechnology to create oligosaccharides that mimic those found in human milk. This approach caters to a growing consumer base seeking alternatives that are both effective and sustainable, appealing especially to those concerned about the environmental impact of traditional production methods. As such, the evolution of these sources is pivotal in shaping the future landscape of the market.

By Form: Powder (Largest) vs. Liquid (Fastest-Growing)

The US human milk-oligosaccharides market exhibits a diverse distribution in its 'Form' segment, where Powder products hold the largest market share. Powdered human milk-oligosaccharides are preferred for their convenience and ease of transport, catering to both consumers and manufacturers. Liquid formulations, while smaller in market share, are gaining traction due to their ready-to-use nature, appealing to consumers seeking quick and effective solutions. In terms of growth trends, Liquid products are experiencing rapid expansion, driven by the increasing demand for convenient feeding solutions among busy parents. The rising awareness about the health benefits of human milk-oligosaccharides is further propelling the market for these liquid forms. Concurrently, the Powder segment remains a dominant force due to its established presence and consumer trust, though it faces competition from innovative liquid formulations.

Powder (Dominant) vs. Liquid (Emerging)

Powdered human milk-oligosaccharides occupy a dominant position in the market, characterized by their long shelf life and versatile application in various food products. These powdered forms are widely used in infant formulas and nutritional supplements, making them a staple choice among manufacturers. Meanwhile, Liquid formulations are emerging as an attractive alternative, providing instant usability that appeals to modern parents. The popularity of Liquid products is rising due to the ease of serving and the growing trend for on-the-go nutrition. Both segment values reflect the evolving consumer preferences in the US human milk-oligosaccharides market, balancing convenience with traditional usage.

By End Use: Healthcare (Largest) vs. Food and Beverages (Fastest-Growing)

In the US human milk-oligosaccharides market, the healthcare segment holds the largest market share, driven by the increasing recognition of health benefits associated with oligosaccharides, particularly for infant nutrition and gut health. The food and beverages sector is rapidly gaining traction, appealing to adults looking for functional foods, which suggests a growing consumer awareness of the advantages of these components in everyday diets. Growth trends indicate that consumer demand for health-oriented products continues to rise, especially as more studies underscore the importance of oligosaccharides in immune support and gut microbiome enhancement. Moreover, the expansion of e-commerce and innovative product formulations in the food and beverage space contribute significantly to the growth velocity of this segment, making it a focal point for manufacturers looking to capitalize on evolving market dynamics.

Healthcare: Healthcare (Dominant) vs. Food and Beverages (Emerging)

The healthcare segment is characterized by its established position amidst robust demand for infant nutritional products, leveraging the proven benefits of human milk-oligosaccharides. It appeals primarily to parents seeking optimal nutrition for their children, positioning itself as a trusted choice in pediatric health. Conversely, the food and beverages segment is emerging as a key player, driven by innovation and consumer shifts towards health-focused food options. This segment is attracting companies eager to explore new product lines that enhance dietary habits. The adaptability of oligosaccharides in various formulations allows for greater consumer access, driving interest and growth, particularly among health-conscious adults.

Get more detailed insights about US Human Milk Oligosaccharides Market

Key Players and Competitive Insights

The human milk-oligosaccharides market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding the health benefits of oligosaccharides, particularly in infant nutrition. Key players such as Nestle (CH), Danone (FR), and Ginkgo Bioworks (US) are actively shaping the market through innovative product offerings and strategic partnerships. Nestle (CH) has positioned itself as a leader in the sector by focusing on research and development, particularly in the formulation of infant formulas enriched with human milk oligosaccharides. Meanwhile, Danone (FR) emphasizes sustainability in its operations, aiming to enhance its product portfolio with environmentally friendly practices. Ginkgo Bioworks (US) leverages its synthetic biology capabilities to develop novel oligosaccharide products, indicating a trend towards biotechnological advancements in the market.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and enhance responsiveness to market demands. The competitive structure of the market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like FrieslandCampina (NL) and Synlogic (US) suggests a trend towards consolidation, as these firms seek to optimize their operations and expand their geographic reach.

In October 2025, FrieslandCampina (NL) announced a strategic partnership with a leading biotechnology firm to enhance its research capabilities in human milk oligosaccharides. This collaboration is expected to accelerate the development of innovative products, thereby strengthening FrieslandCampina's market position. The strategic importance of this partnership lies in its potential to leverage cutting-edge research, which could lead to the introduction of new, differentiated products that meet evolving consumer preferences.

In September 2025, Synlogic (US) launched a new product line that incorporates human milk oligosaccharides aimed at improving gut health in infants. This move not only diversifies Synlogic's product offerings but also aligns with the growing consumer demand for functional foods. The introduction of this product line is significant as it reflects a broader trend towards health-focused nutrition, which is likely to resonate well with health-conscious parents.

In August 2025, Ginkgo Bioworks (US) secured a multi-million dollar investment to expand its production capabilities for human milk oligosaccharides. This investment is poised to enhance Ginkgo's ability to meet increasing market demand while also positioning the company as a key player in the biomanufacturing space. The strategic importance of this expansion lies in its potential to improve supply chain reliability and reduce production costs, thereby enhancing Ginkgo's competitive edge.

As of November 2025, the competitive trends in the human milk-oligosaccharides market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing operational efficiencies. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to those focused on innovation, technological advancements, and supply chain reliability, suggesting a transformative shift in how companies compete in this evolving market.

Key Companies in the US Human Milk Oligosaccharides Market market include

Industry Developments

Recent developments in the US Human Milk Oligosaccharides Market highlight significant growth and interest from major companies. Ginkgo BioWorks is focusing on biomanufacturing solutions to enhance the production of Human Milk Oligosaccharides, while Abbott Laboratories and Nestle continue to expand their product lines featuring these ingredients, aiming to cater to the growing demand for infant nutrition. In September 2023, Nielsen reported a substantial increase in demand for products containing Human Milk Oligosaccharides, indicating increasing consumer awareness about their benefits in infant formula.

Notable mergers include Tate and Lyle's acquisition of a smaller firm to boost its capabilities in functional sweeteners, relevant to the Human Milk Oligosaccharides market. Furthermore, FrieslandCampina and Prolacta Bioscience have been collaborating on Research and Development initiatives to advance the applications of Human Milk Oligosaccharides in health products, aligning with a broader trend towards enhancing infant health. The market valuation of US-based companies has seen upward trends, attributed to rising investments and innovations in this sector, emphasizing the significance of R&D and strategic partnerships.

In the last two years, increased consumer interest and regulatory support have further accelerated growth opportunities within this specialized market.

Future Outlook

US Human Milk Oligosaccharides Market Future Outlook

The human milk-oligosaccharides market is projected to grow at a 14.28% CAGR from 2024 to 2035, driven by increasing consumer awareness and demand for infant nutrition.

New opportunities lie in:

  • Development of customized HMO blends for specific health conditions.
  • Expansion into e-commerce platforms for direct consumer sales.
  • Partnerships with healthcare providers for product recommendations.

By 2035, the market is expected to achieve substantial growth and innovation.

Market Segmentation

US Human Milk Oligosaccharides Market Form Outlook

  • Powder
  • Liquid
  • Capsules

US Human Milk Oligosaccharides Market Source Outlook

  • Human Milk
  • Synthetic Production
  • Animal Milk

US Human Milk Oligosaccharides Market End Use Outlook

  • Healthcare
  • Food and Beverages
  • Nutraceuticals

US Human Milk Oligosaccharides Market Application Outlook

  • Infant Formula
  • Functional Foods
  • Dietary Supplements

Report Scope

MARKET SIZE 2024 121.8(USD Million)
MARKET SIZE 2025 139.19(USD Million)
MARKET SIZE 2035 528.76(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 14.28% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Nestle (CH), Danone (FR), Bifidobacterium (DE), FrieslandCampina (NL), Synlogic (US), Ginkgo Bioworks (US), Ferring Pharmaceuticals (CH), Evolva (CH)
Segments Covered Application, Source, Form, End Use
Key Market Opportunities Growing demand for infant nutrition products enhances opportunities in the human milk-oligosaccharides market.
Key Market Dynamics Rising consumer demand for infant nutrition drives innovation in human milk-oligosaccharides formulations and applications.
Countries Covered US

Leave a Comment

FAQs

What is the expected market size of the US Human Milk Oligosaccharides Market in 2024?

The US Human Milk Oligosaccharides Market is expected to be valued at 130.5 million USD in 2024.

What will be the market valuation of the US Human Milk Oligosaccharides Market by 2035?

By 2035, the US Human Milk Oligosaccharides Market is projected to be valued at 562.5 million USD.

What is the anticipated CAGR for the US Human Milk Oligosaccharides Market between 2025 and 2035?

The expected CAGR for the US Human Milk Oligosaccharides Market during the forecast period from 2025 to 2035 is 14.204%.

What market segment of Human Milk Oligosaccharides is projected to have the largest value in 2035?

The Infant Formula segment is projected to reach a value of 225.0 million USD by 2035.

How much is the Functional Foods segment of the US Human Milk Oligosaccharides Market expected to be worth in 2024?

The Functional Foods segment is valued at 40.0 million USD in the year 2024.

What is the projected market size for Dietary Supplements in 2035?

The Dietary Supplements segment is expected to be valued at 167.5 million USD in 2035.

Who are the key players in the US Human Milk Oligosaccharides Market?

Major players include Ginkgo BioWorks, Tate and Lyle, PepsiCo, Abbott Laboratories, and Nestle.

Which application segment is expected to drive growth in the US Human Milk Oligosaccharides Market?

The application segment of Infant Formula is expected to be a significant driver of growth in the market.

Is there any emerging trend in the US Human Milk Oligosaccharides Market?

There is a notable trend toward increasing demand for infant nutrition products incorporating Human Milk Oligosaccharides.

What challenges might this market face in the coming years?

The market could face challenges related to regulatory requirements and competition from alternative ingredients.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions